ZIVO Bioscience, Inc. (ZIVO)

USD 16.02

(-15.68%)

Gross Profit Summary of ZIVO Bioscience, Inc.

  • ZIVO Bioscience, Inc.'s latest annual gross profit in 2023 was 11.61 Thousand USD , down 0.0% from previous year.
  • ZIVO Bioscience, Inc.'s latest quarterly gross profit in 2024 Q1 was 12.5 Thousand USD , up 202.64% from previous quarter.
  • ZIVO Bioscience, Inc. reported a annual gross profit of - USD in annual gross profit 2022, down 0.0% from previous year.
  • ZIVO Bioscience, Inc. reported a annual gross profit of - USD in annual gross profit 2021, down -100.0% from previous year.
  • ZIVO Bioscience, Inc. reported a quarterly gross profit of 12.5 Thousand USD for 2024 Q1, up 202.64% from previous quarter.
  • ZIVO Bioscience, Inc. reported a quarterly gross profit of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Gross Profit Chart of ZIVO Bioscience, Inc. (2023 - 2000)

Historical Annual Gross Profit of ZIVO Bioscience, Inc. (2023 - 2000)

Year Gross Profit Gross Profit Growth
2023 11.61 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 20 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 100.0%
2011 -34.36 Thousand USD -211.14%
2010 30.91 Thousand USD 100.16%
2009 15.44 Thousand USD -67.04%
2008 46.86 Thousand USD 812.05%
2007 -6582.00 USD -114.82%
2006 44.41 Thousand USD 146.42%
2005 -95.69 Thousand USD -264.89%
2004 -26.22 Thousand USD -14231.15%
2003 -183.00 USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%

Peer Gross Profit Comparison of ZIVO Bioscience, Inc.

Name Gross Profit Gross Profit Difference
America Great Health 168.58 Thousand USD 93.113%
Ampio Pharmaceuticals, Inc. -250 Thousand USD 104.644%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. -551 Thousand USD 102.107%
Bio-Path Holdings, Inc. -178 Thousand USD 106.522%
Better Therapeutics, Inc. -2.72 Million USD 100.425%
Calithera Biosciences, Inc. -1.38 Million USD 100.838%
Comera Life Sciences Holdings, Inc. 422.71 Thousand USD 97.253%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. -22.91 Million USD 100.051%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. -1.02 Million USD 101.137%
Finch Therapeutics Group, Inc. -7.09 Million USD 100.164%
Galera Therapeutics, Inc. -259 Thousand USD 104.483%
Innovation1 Biotech Inc. -52.69 Thousand USD 122.031%
Kiromic BioPharma, Inc. -2.79 Million USD 100.415%
Molecular Templates, Inc. 50.39 Million USD 99.977%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD 109.732%
NexImmune, Inc. -1.02 Million USD 101.133%
Orgenesis Inc. -5.72 Million USD 100.203%
Panbela Therapeutics, Inc. -25.64 Million USD 100.045%
Point of Care Nano-Technology, Inc. -4601.00 USD 352.336%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 29.38 Million USD 99.96%
Statera Biopharma, Inc. -488.31 Thousand USD 102.378%
TRACON Pharmaceuticals, Inc. -232 Thousand USD 105.004%
Trevena, Inc. 1.45 Million USD 99.202%
Vaxxinity, Inc. -2.23 Million USD 100.52%
Vaccinex, Inc. -16 Million USD 100.073%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. -492 Thousand USD 102.36%